Skip to content

Treat patients with choledocholithiasis conbined with cholecystolithiasis by ERCP gallbladder-preserving cholecystolithotomy

Treat patients with choledocholithiasis conbined with cholecystolithiasis by ERCP gallbladder-preserving cholecystolithotomy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900028006
Enrollment
Unknown
Registered
2019-12-08
Start date
2020-01-01
Completion date
Unknown
Last updated
2019-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cholelithiasis

Interventions

gallbladder-preserving:Choledocholithiasis and cholecystolithiasis were taken at the same time by ERCP
Cholecystectomy group:ERCP+LC

Sponsors

The First Affiliated Hospital of Nanchang University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. aged 18-80 years; 2. preoperative abdominal ultrasonography, CT or MRCP and other imaging examinations confirmed choledocholithiasis with cholecystolithiasis, but no intrahepatic bile duct stones, and cholecystolithiasis without chronic cholecystitis; 3. gallbladder stones =75% and wall thickness <=3mm); (6) willing to sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. previous history of ERCP surgery; 2. previous history of biliary tract surgery; 3. patients with intrahepatic bile duct stones; 4. patients with cholangiopancreatic duct tumor; 5. Mirrizzi syndrome; 6. combined with biliary stricture; 7. patients with coagulation dysfunction (INR > 1.5, PT > 2 times the upper limit of reference value) and hemorrhagic diseases; 8. patients with severe heart failure, severe renal failure and severe shock; 9. mental abnormality or extreme lack of cooperation; 10. obstruction of the upper digestive tract; 11. women who are pregnant and breast-feeding or who do not exclude the possibility of pregnancy; 12. follow-up time less than 1 year after treatment; 13. patients who did not sign the informed consent for operation.

Design outcomes

Primary

MeasureTime frame
The incidence of bile duct injury (or bile leakage), the success rate of operation, the stone removal rate;

Secondary

MeasureTime frame
the improvement of transaminase and bilirubin after operation, and the recent complications: pancreatitis, perforation, bleeding, infection, etc. after operation; follow up the recurrence of gallstone and common bile duct stone;Hospital stay, cost of hospitalization;

Countries

China

Contacts

Public ContactYang Zhenzhen

The First Affiliated Hospital of Nanchang University

yangzzjx@163.com+86 15879007297

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 10, 2026